US-20260124392-A1 - INTELLIGENT DOSING PLATFORM WITH ATHLETIC COMPETITION COMPLIANCE AND ANTI-DOPING INTEGRATION FOR INJECTABLE MEDICATION ADMINISTRATION

US20260124392A1US 20260124392 A1US20260124392 A1US 20260124392A1US-20260124392-A1

Abstract

An intelligent dosing platform incorporating comprehensive athletic competition compliance and anti-doping integration capabilities for injectable medication administration across Olympic competitions, professional athletics, and collegiate sports. The platform includes competition compliance modules configured to monitor medication administration while ensuring adherence to competition rules and anti-doping regulations, drug testing integration modules that coordinate with World Anti-Doping Agency (WADA) systems and national anti-doping organizations, and athlete monitoring modules that track therapeutic use exemption compliance. The system features real-time monitoring capabilities during training periods and competition events, alert systems for potential violations and compliance deviations, and documentation modules maintaining tamper-proof records for regulatory bodies. Therapeutic use exemption management modules validate medically necessary treatments against sport-specific regulations, while secure communication modules facilitate coordination between athletes, medical staff, competition officials, and anti-doping authorities. The platform incorporates substance verification, compliance scoring, and data analytics capabilities for comprehensive athletic medication compliance management.

Inventors

Jeremy Corbett

Assignees

DATADOSE, LLC

Dates

Publication Date: 20260507
Application Date: 20251029

Claims (20)

1 . An athletic competition medication monitoring system for injectable medications, comprising: a competition compliance module configured to monitor injectable medication administration in one or more athletic sporting events; a drug testing integration module configured to coordinate with one or more of anti-doping agencies, testing laboratories, and competition oversight bodies; and an athlete monitoring module configured to track medication administration while ensuring compliance with one or more of competition rules, anti-doping regulations, and therapeutic use exemption requirements.
2 . The athletic competition medication monitoring of claim 1 , wherein the competition compliance module is configured to monitor administration across one or more of Olympic competitions, professional athletics, collegiate sports, and amateur sporting events.
3 . The athletic competition medication monitoring of claim 1 , wherein the drug testing integration module is configured to coordinate with one or more of World Anti-Doping Agency (WADA) systems, national anti-doping organizations, and sport-specific testing authorities.
4 . The athletic competition medication monitoring of claim 1 , wherein the athlete monitoring module is configured to verify therapeutic use exemptions for one or more of medically necessary treatments, prescription medications, and approved therapeutic interventions.
5 . The athletic competition medication monitoring of claim 1 , further comprising a medication authentication module configured to verify one or more of drug authenticity, proper storage conditions, and chain of custody documentation for competition-approved substances.
6 . The athletic competition medication monitoring of claim 1 , further comprising a real-time alert system configured to notify relevant parties of one or more of potential violations, prohibited substance detection, and compliance deviations.
7 . The athletic competition medication monitoring of claim 1 , wherein the competition compliance module is configured to track administration timing relative to one or more of competition schedules, testing windows, and regulatory deadlines.
8 . The athletic competition medication monitoring of claim 1 , further comprising a documentation system configured to maintain tamper-proof records for one or more of regulatory bodies, sports organizations, and medical review boards.
9 . The athletic competition medication monitoring of claim 1 , wherein the athlete monitoring module is configured to integrate with one or more of athlete management systems, team medical records, and competition registration databases.
10 . A comprehensive athletic competition medication compliance and monitoring system, comprising: a competition compliance module configured to monitor injectable medication administration in one or more of Olympic competitions, international sporting events, professional athletics, and collegiate sports; a drug testing integration module configured to coordinate with one or more of anti-doping agencies, testing laboratories, and competition oversight bodies; an athlete monitoring module configured to track medication administration while ensuring compliance with one or more of competition rules, anti-doping regulations, and therapeutic use exemption requirements; a therapeutic use exemption management module configured to validate and track one or more of medically necessary treatments, prescription medications, and approved therapeutic interventions; a real-time monitoring module configured to provide oversight during one or more of training periods, competition events, and recovery phases; an alert system configured to notify relevant parties of one or more of potential violations, medication interactions, and compliance issues; a documentation module configured to maintain records for one or more of regulatory bodies, sports organizations, and medical review boards; and a secure communication module configured to facilitate coordination between one or more of athletes, medical staff, competition officials, and anti-doping authorities.
11 . The comprehensive athletic competition medication compliance and monitoring system of claim 10 , wherein the therapeutic use exemption management module is configured to validate exemptions based on one or more of medical necessity criteria, sport-specific regulations, and international anti-doping standards.
12 . The system of claim 10 , wherein the real-time monitoring module is configured to track administration events during one or more of pre-competition periods, active competition timeframes, and post-competition recovery phases.
13 . The comprehensive athletic competition medication compliance and monitoring system of claim 10 , wherein the alert system is configured to escalate notifications based on one or more of violation severity levels, competition proximity, and regulatory response requirements.
14 . The comprehensive athletic competition medication compliance and monitoring system of claim 10 , wherein the documentation module is configured to generate reports for one or more of anti-doping agencies, international sports federations, and national governing bodies.
15 . The comprehensive athletic competition medication compliance and monitoring system of claim 10 , wherein the secure communication module is configured to provide encrypted communications between one or more of team physicians, anti-doping officials, and competition medical personnel.
16 . The comprehensive athletic competition medication compliance and monitoring system of claim 10 , further comprising a substance verification module configured to confirm one or more of medication authenticity, proper storage temperatures, and prohibited substance absence through automated testing integration.
17 . The comprehensive athletic competition medication compliance and monitoring system of claim 10 , further comprising a compliance scoring module configured to calculate adherence ratings based on one or more of regulatory compliance percentages, therapeutic use exemption validity, and testing cooperation metrics.
18 . The comprehensive athletic competition medication compliance and monitoring system of claim 10 , wherein the competition compliance module is configured to adapt monitoring protocols based on one or more of sport-specific regulations, competition levels, and international federation requirements.
19 . The comprehensive athletic competition medication compliance and monitoring system of claim 10 , further comprising a data analytics module configured to identify patterns in one or more of medication usage trends, compliance violations, and therapeutic exemption requests across different sports and competition levels.
20 . A computer-implemented method for athletic competition medication compliance monitoring, comprising: monitoring, via a competition compliance module, injectable medication administration in one or more of Olympic competitions, international sporting events, professional athletics, and collegiate sports; coordinating, via a drug testing integration module, with one or more of anti-doping agencies, testing laboratories, and competition oversight bodies; tracking, via an athlete monitoring module, medication administration while ensuring compliance with one or more of competition rules, anti-doping regulations, and therapeutic use exemption requirements; validating and tracking, via a therapeutic use exemption management module, one or more of medically necessary treatments, prescription medications, and approved therapeutic interventions; providing, via a real-time monitoring module, oversight during one or more of training periods, competition events, and recovery phases; notifying, via an alert system, relevant parties of one or more of potential violations, medication interactions, and compliance issues; maintaining, via a documentation module, records for one or more of regulatory bodies, sports organizations, and medical review boards; facilitating, via a secure communication module, coordination between one or more of athletes, medical staff, competition officials, and anti-doping authorities; verifying, via a substance verification module, one or more of medication authenticity, proper storage temperatures, and prohibited substance absence; calculating, via a compliance scoring module, adherence ratings based on one or more of regulatory compliance percentages, therapeutic use exemption validity, and testing cooperation metrics; adapting, via the competition compliance module, monitoring protocols based on one or more of sport-specific regulations, competition levels, and international federation requirements; and identifying, via a data analytics module, patterns in one or more of medication usage trends, compliance violations, and therapeutic exemption requests across different sports and competition levels.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a continuation of International Application No. PCT/US2025/053140, filed on Oct. 29, 2025, which is a continuation of U.S. patent application Ser. No. 19/373,017, filed on Oct. 29, 2025, which is a continuation-in-part of U.S. patent application Ser. No. 19/314,854, filed on Aug. 29, 2025, which is a continuation-in-part of U.S. patent application Ser. No. 19/281,005, filed on Jul. 25, 2025, which is a continuation of U.S. patent application Ser. No. 19/031,862, filed on Jan. 18, 2025, which is a continuation of U.S. patent application Ser. No. 19/030,829, filed on Jan. 17, 2025, which claims the benefit of U.S. provisional application No. 63/715,505, filed on Nov. 1, 2024, which are all hereby incorporated by reference in their entirety. FIELD The present disclosure relates generally to a management platform for injection devices, such as syringes, and, more particularly, to data reporting regarding administration completion of an injectable pharmaceutical. BACKGROUND Understanding administration of drugs and their interaction in the healthcare ecosystem are important in delivering beneficial patient care. Applicant appreciates that regular pharmaceutical therapy and a need for real time data management related to both timing of and compliance in dosing bundled with increased information sharing across the care continuum can provide valuable insight for improving care and, in turn, reducing fraud, waste, and abuse. SUMMARY In some aspects, the techniques described herein relate to an athletic competition medication monitoring system for injectable medications, including: a competition compliance module configured to monitor injectable medication administration in one or more athletic sporting events; a drug testing integration module configured to coordinate with one or more of anti-doping agencies, testing laboratories, and competition oversight bodies; and an athlete monitoring module configured to track medication administration while ensuring compliance with one or more of competition rules, anti-doping regulations, and therapeutic use exemption requirements. In some aspects, the techniques described herein relate to a system, wherein the competition compliance module is configured to monitor administration across one or more of Olympic competitions, professional athletics, collegiate sports, and amateur sporting events. In some aspects, the techniques described herein relate to a system, wherein the drug testing integration module is configured to coordinate with one or more of World Anti-Doping Agency (WADA) systems, national anti-doping organizations, and sport-specific testing authorities. In some aspects, the techniques described herein relate to a system, wherein the athlete monitoring module is configured to verify therapeutic use exemptions for one or more of medically necessary treatments, prescription medications, and approved therapeutic interventions. In some aspects, the techniques described herein relate to a system, further including a medication authentication module configured to verify one or more of drug authenticity, proper storage conditions, and chain of custody documentation for competition-approved substances. In some aspects, the techniques described herein relate to a system, further including a real-time alert system configured to notify relevant parties of one or more of potential violations, prohibited substance detection, and compliance deviations. In some aspects, the techniques described herein relate to a system, wherein the competition compliance module is configured to track administration timing relative to one or more of competition schedules, testing windows, and regulatory deadlines. In some aspects, the techniques described herein relate to a system, further including a documentation system configured to maintain tamper-proof records for one or more of regulatory bodies, sports organizations, and medical review boards. In some aspects, the techniques described herein relate to a system, wherein the athlete monitoring module is configured to integrate with one or more of athlete management systems, team medical records, and competition registration databases. In some aspects, the techniques described herein relate to a comprehensive athletic competition medication compliance and monitoring system, including: a competition compliance module configured to monitor injectable medication administration in one or more of Olympic competitions, international sporting events, professional athletics, and collegiate sports; a drug testing integration module configured to coordinate with one or more of anti-doping agencies, testing laboratories, and competition oversight bodies; an athlete monitoring module configured to track medication administration while ensuring compliance with one or more of competition rules, anti-doping regulations, and therapeutic use exemption requirements; a therapeutic use exemption manag